Comparison of Magnetic Resonance Imaging-Based Radiomics Features with Nomogram for Prediction of Prostate Cancer Invasion

References

• Li M, Chen T, Zhao W, et al. Radiomics prediction model for the improved diagnosis of clinically significant prostate cancer on biparametric MRI. Quant Imaging Med Surg. 2020;10(2):368–379. doi:10.21037/qims.2019.12.06
   PubMed Web of Science ®Google Scholar
• Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A. Recent global patterns in prostate cancer incidence and mortality rates. Eur Urol. 2020;77(1):38–52. doi:10.1016/j.eururo.2019.08.005
   PubMed Web of Science ®Google Scholar
• Feng RM, Zong YN, Cao SM, Xu RH. Current cancer situation in China: good or bad news from the 2018 global cancer statistics? Cancer Commun. 2019;39(1):22. doi:10.1186/s40880-019-0368-6
   PubMed Web of Science ®Google Scholar
• Caverly TJ, Hayward RA, Reamer E, et al. Presentation of benefits and harms in us cancer screening and prevention guidelines: systematic review. J Natl Cancer Inst. 2016;108(6):djv436. doi:10.1093/jnci/djv436
   PubMedGoogle Scholar
• Aragona F, Pepe P, Motta M, et al. Incidence of prostate cancer in Sicily: results of a multicenter case-findings protocol. Eur Urol. 2005;47(5):569–574. doi:10.1016/j.eururo.2004.11.007
   PubMed Web of Science ®Google Scholar
• Chen YT, Tsai CH, Chen CL, Yu JS, Chang YH. Development of biomarkers of genitourinary cancer using mass spectrometry-based clinical proteomics. J Food Drug Anal. 2019;27(2):387–403. doi:10.1016/j.jfda.2018.09.005
   PubMed Web of Science ®Google Scholar
• Epstein JI, Egevad L, Amin MB, et al. The 2014 International Society of Urological Pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol. 2016;40(2):244–252. doi:10.1097/PAS.0000000000000530
   PubMed Web of Science ®Google Scholar
• Neuhaus J, Schiffer E, von Wilcke P, et al. Seminal plasma as a source of prostate cancer peptide biomarker candidates for detection of indolent and advanced disease. PLoS One. 2013;8(6):e67514. doi:10.1371/journal.pone.0067514
   PubMed Web of Science ®Google Scholar
• Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016;278(2):563–577. doi:10.1148/radiol.2015151169
   PubMed Web of Science ®Google Scholar
• Liu LT, Chen QY, Tang LQ, et al. Advanced-stage nasopharyngeal carcinoma: restaging system after neoadjuvant chemotherapy on the basis of MR imaging determines survival. Radiology. 2017;282(1):171–181. doi:10.1148/radiol.2016152540
   PubMed Web of Science ®Google Scholar
• Lin J, Xie G, Liao G, et al. Prognostic value of 18F-FDG-PET/CT in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis. Oncotarget. 2017;8(20):33884–33896. doi:10.18632/oncotarget.13934
   PubMedGoogle Scholar
• Mayerhoefer ME, Materka A, Langs G, et al. Introduction to Radiomics. J Nucl Med. 2020;61(4):488–495. doi:10.2967/jnumed.118.222893
   PubMed Web of Science ®Google Scholar
• Huynh E, Coroller TP, Narayan V, et al. Associations of radiomic data extracted from static and respiratory-gated CT scans with disease recurrence in lung cancer patients treated with SBRT. PLoS One. 2017;12(1):e0169172. doi:10.1371/journal.pone.0169172
   PubMed Web of Science ®Google Scholar
• Li T, Sun L, Li Q, et al. Development and validation of a radiomics nomogram for predicting clinically significant prostate cancer in PI-RADS 3 lesions. Front Oncol. 2021;11:825429. doi:10.3389/fonc.2021.825429
   PubMed Web of Science ®Google Scholar
• Jing G, Xing P, Li Z, et al. Prediction of clinically significant prostate cancer with a multimodal MRI-based radiomics nomogram. Front Oncol. 2022;12:918830. doi:10.3389/fonc.2022.918830
   PubMed Web of Science ®Google Scholar
• Pepe P, Pennisi M. Should 68Ga-PSMA PET/CT Replace CT and bone scan in clinical staging of high-risk prostate cancer? Anticancer Res. 2022;42(3):1495–1498. doi:10.21873/anticanres.15621
   PubMed Web of Science ®Google Scholar
• Pepe P, D’Urso D, Garufi A, et al. Multiparametric MRI Apparent Diffusion Coefficient (ADC) accuracy in diagnosing clinically significant prostate cancer. Vivo. 2017;31(3):415–418. doi:10.21873/invivo.11075
   PubMed Web of Science ®Google Scholar
• Huang YQ, Liang CH, He L, et al. Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol. 2016;34(18):2157–2164. doi:10.1200/JCO.2015.65.9128
   PubMed Web of Science ®Google Scholar
• Li H, Zhu Y, Burnside ES, et al. MR imaging radiomics signatures for predicting the risk of breast cancer recurrence as given by research versions of mammaprint, oncotype DX, and PAM50 gene assays. Radiology. 2016;281(2):382–391. doi:10.1148/radiol.2016152110
   PubMed Web of Science ®Google Scholar
• Dong D, Tang L, Li ZY, et al. Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer. Ann Oncol. 2019;30(3):431–438. doi:10.1093/annonc/mdz001
   PubMed Web of Science ®Google Scholar
• Min X, Li M, Dong D, et al. Multi-parametric MRI-based radiomics signature for discriminating between clinically significant and insignificant prostate cancer: cross-validation of a machine learning method. Eur J Radiol. 2019;115:16–21. doi:10.1016/j.ejrad.2019.03.010
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen W, Yue X, et al. Development of a novel, multi-parametric, MRI-based radiomic nomogram for differentiating between clinically significant and insignificant prostate cancer. Front Oncol. 2020;10:888. doi:10.3389/fonc.2020.00888
   PubMed Web of Science ®Google Scholar
• Niu XK, Chen ZF, Chen L, Li J, Peng T, Li X. Clinical application of biparametric MRI texture analysis for detection and evaluation of high-grade prostate cancer in zone-specific regions. AJR Am J Roentgenol. 2018;210(3):549–556. doi:10.2214/AJR.17.18494
   PubMed Web of Science ®Google Scholar
• Nketiah G, Elschot M, Kim E, et al. T2-weighted MRI-derived textural features reflect prostate cancer aggressiveness: preliminary results. Eur Radiol. 2017;27(7):3050–3059. doi:10.1007/s00330-016-4663-1
   PubMed Web of Science ®Google Scholar
• Fan Y, Hua M, Mou A, et al. Preoperative noninvasive radiomics approach predicts tumor consistency in patients with acromegaly: development and multicenter prospective validation. Front Endocrinol. 2019;10:403. doi:10.3389/fendo.2019.00403
   PubMed Web of Science ®Google Scholar
• Yip SSF, Liu Y, Parmar C, et al. Associations between radiologist-defined semantic and automatically computed radiomic features in non-small cell lung cancer. Sci Rep. 2017;7(1):3519. doi:10.1038/s41598-017-02425-5
   PubMedGoogle Scholar
• Jiang W, Wang S, Wan J, et al. Association of the collagen signature with pathological complete response in rectal cancer patients. Cancer Sci. 2022;113(7):2409–2424. doi:10.1111/cas.15385
   PubMed Web of Science ®Google Scholar
• Su Y, Lu C, Zheng S, et al. Precise prediction of the sensitivity of platinum chemotherapy in SCLC: establishing and verifying the feasibility of a CT-based radiomics nomogram. Front Oncol. 2023;13:1006172. doi:10.3389/fonc.2023.1006172
   PubMed Web of Science ®Google Scholar
• Du R, Lee VH, Yuan H, et al. Radiomics model to predict early progression of nonmetastatic nasopharyngeal carcinoma after intensity modulation radiation therapy: a multicenter study. Radiol Artif Intell. 2019;1(4):e180075. doi:10.1148/ryai.2019180075
   PubMedGoogle Scholar
• Molina-Garcia D, Garcia-Vicente AM, Perez-Beteta J, et al. Intratumoral heterogeneity in (18)F-FDG PET/CT by textural analysis in breast cancer as a predictive and prognostic subrogate. Ann Nucl Med. 2018;32(6):379–388. doi:10.1007/s12149-018-1253-0
   PubMed Web of Science ®Google Scholar